News | Ventricular Assist Devices (VAD) | November 02, 2022

Study Sifts Potential Factors of Device-Implant Complication

Machine learning identified preoperative conditions associated with poor outcomes of left-ventricle assist device surgery. 

About one-fifth of implants of left ventricular-assist devices have the complication of right heart failure. Abbott Laboratories (adapted)

About one-fifth of implants of left ventricular-assist devices have the complication of right heart failure. Abbott Laboratories (adapted)


November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts have grown too weak to effectively pump blood to the body. For upward of 20% of those patients, though, an LVAD implant gives rise to a dreaded complication: Their right ventricle fails, typically within days.

Cardiac specialists think it’s because the right heart cannot accommodate the suddenly resurgent blood flow from the just-installed pump. When right-heart failure is recognized, the patients receive intravenous medications and temporary mechanical support. In some cases, but not all, these emergency interventions improve the right ventricle’s viability.

Knowing beforehand which patients are at a higher risk to develop right-heart failure might enable doctors to reduce that likelihood.

Researchers at UW Medicine in Seattle today report findings of a machine-learning analysis of 186 pre-implant patient factors, revealing the 30 most strongly associated with right-heart failure among a population of 19,595 first-time LVAD recipients.

Their paper was published Oct. 26 in the ASAIO Journal.

“We had two objectives with this study: to help predict which patients will develop this complication and to find out if there are factors we can optimize to lower the risk of right-heart failure before we implant the LVAD,” said Dr. Song Li, a heart failure cardiologist at the UW Medicine Heart Institute and the paper’s senior author.

The sheer number of patient variables potentially involved in the complication has precluded cardiologists from easily knowing which ones, alone or in concert, might amplify risk for an LVAD recipient. Cardiologists have generally thought that the best predictor of right-heart failure post-LVAD implant is how the right heart functioned before surgery, Li said.

“We found that conventional wisdom might not be true: Right-heart function before LVAD is not one of the most important variables,” he said.

In this population, right-heart failure was most associated with patients’ liver function, kidney function, inflammation level, nutritional status, and overall preoperative acuity (INTERMACS profile), the authors found.

The puzzle of distinguishing variables’ relative importance was well-suited to an algorithm built to detect associations from a giant pool of data.

“Most traditional studies will come up with one risk factor that’s associated or correlated with an outcome. But for complex problems, it’s nice to be able to look at many variables at the same time,” said Dr. Arjun Bahl, the study’s lead author and a third-year resident in internal medicine.

The algorithm showed patient variables — for example, creatinine level, tobacco-smoking status and race — and their relative contributions to right-heart failure, Bahl said. The analysis also revealed whether a lower or higher variable value was more or less associated with the complication.

“Our machine-learning approach enabled us to move forward without having to create arbitrary cutoffs of levels to identify significance and without having to create subgroups of patients across those levels,” he said.

The researchers’ other consideration was to generate findings that are actionable for cardiologists.

“Now that we have a sense of what factors are more important, what can we do to optimize those before the patient goes into surgery?” Li asked. “Not all factors are modifiable, but for example nutritional status is one we could modify. We should try to give patients more nutrition, to ensure they are optimized before surgery.”

The researchers acknowledged that right-heart failure is not only dependent on presurgical patient factors, and that operative and postoperative care likely have an impact, as well.

For more information: http://www.uwmedicine.org/


Related Content

News | Heart Failure

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million ...

Home June 07, 2024
Home
News | Heart Failure

June 7, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home June 07, 2024
Home
News | Heart Failure

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
Subscribe Now